FTSE 100 dips as heavyweight ex-dividends drag, Lloyds soars The FTSE 100 dropped again on Thursday as companies accounting for a significant proportion of the index traded ex-dividend and…
4 AI Stocks to Watch in the Quantum Computing Revolution Following the stock markets record-breaking 2024, during which the S&P 500 index returned a spectacular 23%, theres optimism among investors…
Directorate Change 18 February 2025 Non-Executive Board Changes AstraZeneca PLC announced today that Karen Knudsen will be proposed for election as a Non-Executive Director…
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…
AZN IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZN NEW YORK, Feb. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025 Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the worlds leading drugmakers, missed last years strong market rally.…
Could IonQ Stock Help You Retire a Millionaire? The hot field of artificial intelligence (AI) helped the stock market reach new highs in 2024. Quantum computing is another…
Morgan Stanley sets AstraZeneca stock Overweight with £145 target By Investing.com Morgan Stanley sets AstraZeneca stock Overweight with £145 target…
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against IIPR, AstraZeneca, FTAI, and Revance and Encourages Investors to Contact the Firm NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…